News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teva Pharmaceutical Industries Limited (TEVA) & Baxter International, Inc. (BAX) May Benefit From Generic Labeling Case


7/28/2011 7:22:03 AM

A recent Supreme Court ruling on pharmaceutical safety warnings is upending a costly wave of product-liability lawsuits against some of the world's largest generic-drug manufacturers. At issue is whether a generic-drug company can be sued for failing to strengthen its warning labels beyond those of the branded versions. Last year, a Las Vegas state jury slapped a $500 million judgment against Teva Pharmaceutical Industries Ltd. and Baxter International Inc. on the grounds that the companies failed to adequately warn doctors against the dangers of reusing vials and syringes when they administered propofol, a generic sedative.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES